ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Micron Tops Analyst Upgrades; Biogen Gets Boost

By ORTEX News · Edited by , Editor, ORTEX News1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Micron Technology dominated Wednesday's analyst activity. The consensus target price rose to $945.60 from $911.85 — a $34 jump driven by multiple upward revisions. The chipmaker carries a $1.15 trillion market cap and just 3.3% short interest. Analysts are clearly bullish on AI-driven memory demand.

Biogen drew the sharpest individual call. Morgan Stanley's Matthew Harrison upgraded the stock to Hold and raised his target to $224 from $206. That's an 8.7% target lift. Biogen trades at roughly $29 billion market cap. Short interest sits at just 3.3% of free float. Availability is extremely high at 1,442% — meaning bears are not piling in.

Energy stocks took hits. Constellation Energy and NRG Energy both saw consensus targets trimmed. Duke Energy also had its target cut slightly to $137.83. Utility downgrades likely reflect cooling sentiment after a hot run in power stocks tied to data centre demand.

Progressive Corp faced a notable cut. B of A's Joshua Shanker slashed his target to $313 from $331, a $18 drop. He kept his Buy rating but flagged near-term valuation concerns.

Jabil bucked the trend. Its consensus target rose to $426 from $414 — a quiet but meaningful 2.8% increase.

Stocks in this article

How this article was generated

Generated
18 Jun 2026, 12:20
Prompt version
v1.0
Data sources
Analyst consensus

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.